OBJECTIVE: The objective of the study was to assess the prevalence and determinants of elevated apolipoprotein B (apoB) and dense low-density lipoprotein (LDL) in United States youth with type 1 or type 2 diabetes. METHODS: We conducted cross-sectional analyses of apoB concentrations, LDL density, and prevalence of elevated apoB levels and dense LDL from the SEARCH for Diabetes in Youth study, a six-center U.S.-based study of youth with diabetes onset younger than 20 years of age (2657 with type 1 and 345 with type 2). RESULTS: Among youth with type 1 diabetes, 11% had elevated apoB (>or=100 mg/dl, 1.95 mm/liter), 8% had dense LDL (relative flotation rate<or=0.237), and 12% had elevated LDL-cholesterol (>or=130 mg/dl, 3.36 mm/liter). In contrast, among youth with type 2 diabetes, 36% had elevated apoB, 36% had dense LDL, but only 23% had elevated LDL-cholesterol. Dense LDL and apoB each increased with hemoglobin A1c in both types. Among type 1 diabetics in poor glycemic control (hemoglobin A1c>or=9.5%), 28% had elevated apoB, and 18% had dense LDL, whereas 72% of poorly controlled type 2 diabetics had elevated apoB and 62% had dense LDL. CONCLUSIONS: In youth with type 1 diabetes, elevated apoB and dense LDL were not highly prevalent, whereas elevated apoB and dense LDL were common lipoprotein abnormalities in youth with type 2 diabetes. The prevalence of these risk factors substantially increased with poor glycemic control in both groups, stressing the importance of achieving and maintaining an optimal glucose control.
OBJECTIVE: The objective of the study was to assess the prevalence and determinants of elevated apolipoprotein B (apoB) and dense low-density lipoprotein (LDL) in United States youth with type 1 or type 2 diabetes. METHODS: We conducted cross-sectional analyses of apoB concentrations, LDL density, and prevalence of elevated apoB levels and dense LDL from the SEARCH for Diabetes in Youth study, a six-center U.S.-based study of youth with diabetes onset younger than 20 years of age (2657 with type 1 and 345 with type 2). RESULTS: Among youth with type 1 diabetes, 11% had elevated apoB (>or=100 mg/dl, 1.95 mm/liter), 8% had dense LDL (relative flotation rate<or=0.237), and 12% had elevated LDL-cholesterol (>or=130 mg/dl, 3.36 mm/liter). In contrast, among youth with type 2 diabetes, 36% had elevated apoB, 36% had dense LDL, but only 23% had elevated LDL-cholesterol. Dense LDL and apoB each increased with hemoglobin A1c in both types. Among type 1 diabetics in poor glycemic control (hemoglobin A1c>or=9.5%), 28% had elevated apoB, and 18% had dense LDL, whereas 72% of poorly controlled type 2 diabetics had elevated apoB and 62% had dense LDL. CONCLUSIONS: In youth with type 1 diabetes, elevated apoB and dense LDL were not highly prevalent, whereas elevated apoB and dense LDL were common lipoprotein abnormalities in youth with type 2 diabetes. The prevalence of these risk factors substantially increased with poor glycemic control in both groups, stressing the importance of achieving and maintaining an optimal glucose control.
Authors: Paul T Williams; H Robert Superko; William L Haskell; Edwin L Alderman; Patricia J Blanche; Laura Glines Holl; Ronald M Krauss Journal: Arterioscler Thromb Vasc Biol Date: 2003-02-01 Impact factor: 8.311
Authors: A S Krolewski; E J Kosinski; J H Warram; O S Leland; E J Busick; A C Asmal; L I Rand; A R Christlieb; R F Bradley; C R Kahn Journal: Am J Cardiol Date: 1987-04-01 Impact factor: 2.778
Authors: Janet K Snell-Bergeon; Nancy A West; Elizabeth J Mayer-Davis; Angela D Liese; Santica M Marcovina; Ralph B D'Agostino; Richard F Hamman; Dana Dabelea Journal: J Clin Endocrinol Metab Date: 2010-04-06 Impact factor: 5.958
Authors: Angela D Liese; Andrey Bortsov; Anke L B Günther; Dana Dabelea; Kristi Reynolds; Debra A Standiford; Lenna Liu; Desmond E Williams; Elizabeth J Mayer-Davis; Ralph B D'Agostino; Ronny Bell; Santica Marcovina Journal: Circulation Date: 2011-03-21 Impact factor: 29.690
Authors: Petter Bjornstad; Nhung Nguyen; Christina Reinick; David M Maahs; Franziska K Bishop; Scott A Clements; Janet K Snell-Bergeon; Rachel Lieberman; Laura Pyle; Stephen R Daniels; R Paul Wadwa Journal: Acta Diabetol Date: 2014-12-25 Impact factor: 4.280
Authors: John Guy; Lorraine Ogden; R Paul Wadwa; Richard F Hamman; Elizabeth J Mayer-Davis; Angela D Liese; Ralph D'Agostino; Santica Marcovina; Dana Dabelea Journal: Diabetes Care Date: 2008-12-17 Impact factor: 19.112
Authors: Ronny A Bell; Elizabeth J Mayer-Davis; Jennifer W Beyer; Ralph B D'Agostino; Jean M Lawrence; Barbara Linder; Lenna L Liu; Santica M Marcovina; Beatriz L Rodriguez; Desmond Williams; Dana Dabelea Journal: Diabetes Care Date: 2009-03 Impact factor: 19.112